NO985979D0 - 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse - Google Patents

1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse

Info

Publication number
NO985979D0
NO985979D0 NO985979A NO985979A NO985979D0 NO 985979 D0 NO985979 D0 NO 985979D0 NO 985979 A NO985979 A NO 985979A NO 985979 A NO985979 A NO 985979A NO 985979 D0 NO985979 D0 NO 985979D0
Authority
NO
Norway
Prior art keywords
preparation
benzothiadiazine derivatives
compounds
benzothiadiazine
derivatives
Prior art date
Application number
NO985979A
Other languages
English (en)
Other versions
NO985979L (no
Inventor
Bernard Pirotte
Philippe Lebrun
Pascal De Tullio
Fabian Somers
Jacques Delarge
John Bondo Hansen
Flemming Elmelund Nielsen
Holger Claus Hansen
John Patrick Mogensen
Tina M Ller Tagmose
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO985979D0 publication Critical patent/NO985979D0/no
Publication of NO985979L publication Critical patent/NO985979L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO985979A 1996-06-21 1998-12-18 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse NO985979L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK69396 1996-06-21
DK145196 1996-12-19
PCT/DK1997/000266 WO1997049692A1 (en) 1996-06-21 1997-06-19 1,2,4-benzothiadiazine derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
NO985979D0 true NO985979D0 (no) 1998-12-18
NO985979L NO985979L (no) 1999-02-19

Family

ID=26064470

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985979A NO985979L (no) 1996-06-21 1998-12-18 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse

Country Status (18)

Country Link
US (1) US6242443B1 (no)
EP (1) EP0906297B1 (no)
JP (1) JP2000512641A (no)
KR (1) KR20000022087A (no)
CN (1) CN1081633C (no)
AT (1) ATE260266T1 (no)
AU (1) AU737920B2 (no)
BR (1) BR9709858A (no)
CA (1) CA2258100A1 (no)
CZ (1) CZ413198A3 (no)
DE (1) DE69727806T2 (no)
ES (1) ES2216155T3 (no)
HU (1) HUP9904032A3 (no)
IL (1) IL127368A0 (no)
MX (1) MXPA98010773A (no)
NO (1) NO985979L (no)
PL (1) PL330815A1 (no)
WO (1) WO1997049692A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2288154A1 (en) * 1997-04-28 1998-11-05 Michael J. Kelley Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
WO1999032467A1 (en) * 1997-12-19 1999-07-01 Novo Nordisk A/S 1,2,4-benzothiadiazine derivatives, their preparation and use
US6943159B1 (en) 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
WO2002000222A1 (en) * 2000-06-26 2002-01-03 Novo Nordisk A/S Use of potassium channel agonists for the treatment of cancer
BR0207865A (pt) 2001-02-14 2004-03-23 Warner Lambert Co Benzotiadiazinas inibidores de metaloproteinases de matriz
CA2536967A1 (en) 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
JP2008531579A (ja) 2005-02-24 2008-08-14 ニトロメッド インコーポレーティッド 酸化窒素増強利尿化合物、組成物および使用方法
JP5306194B2 (ja) * 2006-06-22 2013-10-02 アナディス ファーマシューティカルズ インク ピロ［１，２−ｂ］ピリダジノン化合物
US20090257979A1 (en) * 2008-04-15 2009-10-15 Intermune, Inc. Novel Inhibitors of Hepatitis C Virus Replication
EP2395987A1 (en) 2009-02-12 2011-12-21 Coöperatieve Mirzorg U.A., Arnhem Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
WO2010111518A1 (en) * 2009-03-27 2010-09-30 Yale University Treatment and prevention of white matter injury with katp channel activators
TW201121968A (en) * 2009-11-09 2011-07-01 Intermune Inc Novel inhibitors of hepatitis C virus replication
US10981951B2 (en) 2014-01-31 2021-04-20 Mayo Foundation For Medical Education And Research Therapeutics for the treatment of glaucoma
WO2017098421A1 (en) * 2015-12-08 2017-06-15 Glaxosmithkline Intellectual Property Development Limited Benzothiadiazine compounds
EP3813824A4 (en) 2018-05-11 2022-01-05 University of Florida Research Foundation, Incorporated MYELINIZATION STIMULATING COMPOUNDS AND METHODS OF TREATMENT
NL2022291B1 (en) * 2018-12-21 2020-07-21 Academisch Ziekenhuis Leiden Compound for Use in Treatment and Prevention of Type I Diabetes
CN110903264B (zh) * 2019-12-26 2021-06-18 苏州大学 一种制备二氮嗪的方法
US20230219912A1 (en) * 2020-05-19 2023-07-13 Board Of Regents Of The University Of Nebraska Halogenated benzothiadiazines for the treatment of cancer
WO2024086252A1 (en) * 2022-10-18 2024-04-25 Rhythm Pharmaceuticals, Inc. Novel atp-sensitive potassium channel potentiators, their preparation and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3269906A (en) 1966-08-30 Imino-j,x-dihydro-l,z,x-benzothiadiazine- i,i-dioxides
GB847176A (en) * 1958-06-20 1960-09-07 Lepetit Spa Benzothiadiazine compounds
US4029780A (en) * 1974-10-29 1977-06-14 Dainippon Pharmaceutical Co., Ltd. 3-Piperazinyl 1,2,4-benzothiadiazine 1,1-dioxide derivatives their compositions and method of use
SE402773B (sv) 1976-04-20 1978-07-17 Dainippon Pharmaceutical Co Forfarande for framstellning av 1,2,4-bensotiadiazin-1,1-dioxid-derivat
DE2757922A1 (de) * 1977-12-24 1979-06-28 Bayer Ag Substituierte alkylenamino-1.2.4- benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2757925A1 (de) * 1977-12-24 1979-06-28 Bayer Ag Diazacyclo-1.2.4-benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
CN1222910A (zh) 1999-07-14
ATE260266T1 (de) 2004-03-15
EP0906297A1 (en) 1999-04-07
PL330815A1 (en) 1999-06-07
HUP9904032A3 (en) 2001-11-28
CA2258100A1 (en) 1997-12-31
WO1997049692A1 (en) 1997-12-31
AU3166497A (en) 1998-01-14
BR9709858A (pt) 1999-08-10
KR20000022087A (ko) 2000-04-25
US6242443B1 (en) 2001-06-05
HUP9904032A2 (hu) 2000-03-28
JP2000512641A (ja) 2000-09-26
IL127368A0 (en) 1999-10-28
MXPA98010773A (es) 2002-06-11
CZ413198A3 (cs) 1999-06-16
DE69727806T2 (de) 2005-01-13
NO985979L (no) 1999-02-19
CN1081633C (zh) 2002-03-27
AU737920B2 (en) 2001-09-06
ES2216155T3 (es) 2004-10-16
EP0906297B1 (en) 2004-02-25
DE69727806D1 (de) 2004-04-01

Similar Documents

Publication Publication Date Title
NO985979D0 (no) 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse
DK1140945T3 (da) Kondenserede 1,2,4-thiadiazinderivater, deres fremstilling og anvendelse
DE69840519D1 (de) Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
ATE188965T1 (de) Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln
DE3876400D1 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
NO995431D0 (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
ATE316529T1 (de) Substituierte pyridylmethylpiperazin- und piperidinderivate, deren herstellung und deren verwendung in der behandlung von erkrankungen des zentralnervensystems (zns)
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
NO983990D0 (no) Aminotetralin-derivater og blandinger og metode for anvendelse derav
ATE264309T1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
NO900643D0 (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
CA2195747A1 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
IL125072A0 (en) Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives their preparation and use
NO903386D0 (no) Fremgangsmaate for fremstilling av 4-(n-substituert amino)-2-butynyl-1-karbamater og -tiokarbamater og derivater derav.
BG101328A (en) New derivatives of imidazoloquinaxalon with heterocyclic substituents, their preparation and use
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
DK0730861T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE3788888D1 (de) Perhydrothiazepin- und Perhydroazepinderivate, ihre Herstellung und ihre therapeutische Verwendung.
UA66755C2 (en) Derivatives of condensed 1,2,4-thiadiazine, a method for the preparation thereof, pharmaceutical composition and a method for treatment or prevention of endocrine system diseases
DK0828740T3 (da) 2-Azabicyclo[2.2.1]heptanderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application